The decision for patients to receive chemotherapy should depend on their response to endocrine therapy and gene expression testing, for patients with ...

Kadcyla (ado-trastuzumab emtansine; T-DM1) outperformed Herceptin (trastuzumab) regarding overall survival (OS; time from treatment until death of any ...

The addition of Tecentriq (atezolizumab) to neoadjuvant Herceptin (trastuzumab) plus Perjeta (pertuzumab) and chemotherapy was shown to improve the number ...

Findings from the phase 3 EMRALD trial showed that all relevant subgroups of patients with ER-positive/HER2-negative, ESR1-mutated advanced or metastatic ...

When I was 12, I was at the height of my childhood theatrical career. My first major role was Baby June in a local, dinner theatre production of Gypsy.“ ...

Major League baseball VP, Billy Bean, revealed his cancer diagnosis.Billy Bean, a MLB VP, recently announced that he was diagnosed with leukemia.Billy Bean, ...

Time to next breast treatment tended to vary based on HER2 status, according to a recent study.A recent study of patients who received Enhertu (trastuzumab ...

Research has shown that Black women with triple-negative breast cancer (TNBC) tend to have higher mortality rates than their White counterparts. According ...

Dato-DXd (datopotamab deruxtecan) compared to chemotherapy showed improvements with progression-free survival (PFS, the time from randomization or ...

The addition of Tukysa (tucatinib) to Kadcyla (ado-trastuzumab emtansine) improved progression-free survival compared with placebo plus Kadcyla.In patients ...